09989.HK
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 4.23
−0.59%Forward multiples
Based on analyst estimates
- P/E forward
- 11.79x
- P/E 2026E
- 6.29x
- P/E 2027E
- 5.37x
- P/E 2028E
- 4.87x
- P/S forward
- 1.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- 25.97x
- PEG TTM
- 0.22x
- Price / book
- 0.45x
- Price / sales
- 1.02x
- Price / cash flow
- 3.55x
Enterprise value
- Enterprise value
- HKD 5.5B
- EV / sales
- 0.90x
- EV / EBITDA
- 13.40x
- EV / EBIT
- 24.61x
- Market cap
- HKD 6.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026